Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 13, 2024Clinical and Experimental MedicineOpen Access

TET2 mutations contribute to adverse prognosis in acute myeloid leukemia (AML): results from a comprehensive analysis of 502 AML cases and the Beat AML public database

View Full Paper
Ask AI
Bookmark
Share

Authors

XPXinan PanYCYing‐Jun ChangPeking UniversityGRGuo‐Rui RuanPeking University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Pan et al. (2024) studied this question.

synapsesocial.com/papers/6a9b0de39bae5972a9a79fa3https://doi.org/10.1007/s10238-024-01297-0
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1<scp><i>TET2</i></scp> as an epigenetic master regulator for normal and malignant hematopoiesis2014 · 109 citations
  2. 2Down-regulation of BRCA1 and BRCA2 in human ovarian cancer cells exposed to adriamycin and ultraviolet radiation1998 · 48 citations
  3. 3Mutation topography and risk stratification for <i>de novo</i> acute myeloid leukaemia with normal cytogenetics and no nucleophosmin 1 (<i>NPM1</i>) mutation or Fms‐like tyrosine kinase 3 internal tandem duplication (<i>FLT3‐</i>ITD)2020 · 19 citations
  4. 4USP15 suppresses tumor immunity via deubiquitylation and inactivation of TET22020 · 49 citations
  5. 5Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia2008 · 1,641 citations